| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701098 | European Journal of Surgical Oncology (EJSO) | 2017 | 10 Pages |
Abstract
Downregulation of REG1α expression can reduce tumor growth, migration, invasion and angiogenesis. Our study demonstrates that REG1α can be used as a marker of recurrence and prognosis in bladder cancer. Therefore, REG1α targeting in bladder cancer patients represents a promising therapeutic strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Geng, J. Fan, Q. Wang, X.-P. Zhang, L. Kang, Q.-Y. Li, Y.-F. Xu, B. Peng, J.-H. Zheng, X.-D. Yao,